BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
6.81
+1.06 (18.43%)
Mar 6, 2026, 4:00 PM EST - Market closed
BiomX Market Cap
BiomX has a market cap or net worth of $10.85 million as of March 6, 2026. Its market cap has decreased by -37.15% in one year.
Market Cap
10.85M
Enterprise Value
7.93M
1-Year Change
-37.15%
Ranking
Category
Stock Price
$6.81
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $10.85M, a decrease of -99.44%. That is a compound annual growth rate of -54.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 9.16M | 220.99% |
| Dec 31, 2025 | 2.85M | -78.49% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 11.50M |
| Soligenix | 11.40M |
| Cellectar Biosciences | 11.28M |
| Imunon | 11.09M |
| Chemomab Therapeutics | 11.08M |
| CalciMedica | 11.02M |
| Liminatus Pharma | 10.67M |
| Moleculin Biotech | 10.61M |